Drug profile · INN
anisindione
MIRADON
anisindione (MIRADON) is a vitamin k-dependent gamma-carboxylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — anisindione
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
anisindione (MIRADON) is a vitamin k-dependent gamma-carboxylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin K-dependent gamma-carboxylase inhibitor
Primary target: Vitamin K-dependent gamma-carboxylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is anisindione?
anisindione (MIRADON) is a vitamin k-dependent gamma-carboxylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for anisindione?
MIRADON is a marketed brand name for anisindione. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of anisindione?
anisindione has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.